Building materials and chemicals company Chongqing Sansheng has revealed its plans to take over a pharmaceutical company also based in China.
Named Liaoyun City Baikang Pharmaceutical, the target company was previously known as Liaoyuan First Pharmaceutical Factory.
Go deeper with GlobalData
The final deal consideration of the acquisition is estimated to be $40.13m.
Recipharm has announced its plan to acquire certain businesses of Kemwell Biopharma.
The sale consideration for the takeover is $205.86m, which will be entirely arranged by Recipharm through various means.
See Also:
Legal advisors to the transaction are Veritas Legal Services, CalissendroffSwarting Advokatbyra KB, and Obermayer Rebmann Maxwell & Hippel LLP.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataPWC Capital is the financial adviser to Recipharm, on the transaction.
Image: Recipharm has announced its plan to acquire certain businesses of Kemwell Biopharma; Photo: courtesy of Kemwell Biopharma.
